CAPHRA Calls for Review of Tobacco Harm Reduction Methods

Dec.13.2022
CAPHRA Calls for Review of Tobacco Harm Reduction Methods
The CAPHRA coalition sent a letter to FCTC representatives urging them to review THR methods for COP10 in Panama.

The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), which comprises of nine member organizations, has written to chiefs of delegations of the Framework Convention on Tobacco Control (FCTC) worldwide, urging them to review methods supporting the reduction of tobacco harm (THR).


As governments from various countries send representatives to attend the 10th Conference of the Parties (COP10) in November 2023, the CAPHRA Alliance is eager to provide comprehensive reference materials to leaders for COP10 planning, submission and deliberation.


The 10th Conference of the Parties (COP10) will be held in Panama and hosted by the World Health Organization's Framework Convention on Tobacco Control.


We represent four million nicotine product users in the Asia-Pacific region. Our region is particularly vulnerable to the dangers and deaths caused by combustible and unsafe oral tobacco worldwide," the letter stated.


Representatives from the CAPHRA alliance have reminded health leaders that the FCTC convention has the authority to consider harm reduction as a core tobacco control policy.


For decades, it has been widely known that the tar and carcinogens found in tobacco smoke lead to smoking-related deaths and illnesses, rather than nicotine. Studies have shown that although nicotine is generally mildly addictive, like caffeine, it is not a health concern, they wrote.


The letter also calls on representatives to condemn the policy of holding the COP10 conference behind closed doors by the FCTC.


They wrote: "COP10 should represent the rights and wishes of the citizens. Their participation fees are paid by taxpayers and it is hoped that they speak for themselves, recognize the scientific benefits of supporting ENDS for harm reduction, and uphold democratic principles," they wrote.


Representatives of the CAPHRA Alliance are requesting that countries take into account consumers' right to make choices that help them avoid negative health outcomes when submitting their COP10 submissions. Additionally, smokers have the right to access nicotine products with lower harm as alternatives to smoking.


A recent white paper titled "Disrupting Public Health: A Consumer Perspective" was presented by Nancy Loucas, the executive coordinator of the CAPHRA alliance, at the 5th Asia Harm Reduction Forum. The evidence-based document was included in the presentation.


2FIRSTS will continue to cover this issue, with updates available on the "2FIRSTS APP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
JT Q3 2025: Revenue +18%, Profit +30%; RRP Volume +40%; Guidance Up
JT Q3 2025: Revenue +18%, Profit +30%; RRP Volume +40%; Guidance Up
Japan Tobacco (JT) delivered a strong Q3 2025. Revenue rose 18.3% year over year to ¥947.2 billion, with adjusted operating profit up 27.8% to ¥279.0 billion (+20.8% at constant currency) and net profit up 29.7% to ¥176.7 billion. Growth was led by reduced-risk products (RRP): total RRP volume climbed 40%, with heated tobacco (HTS) up 53%. In Japan, the launches of Ploom AURA and EVO pods pushed HTS category share to 15.5%, while the Ploom user base has nearly doubled versus two years ago.
Oct.30 by 2FIRSTS.ai
Product | OXVA launches Artio 2 liquid-tobacco pod device, positioned as distinct from HNB and traditional flavored e-cigarettes
Product | OXVA launches Artio 2 liquid-tobacco pod device, positioned as distinct from HNB and traditional flavored e-cigarettes
OXVA has released its Artio 2 pod device featuring the Liquid Tobacco Intelligent (LTI) platform. It offers around 400 puffs per charge, pods equivalent to about 35 cigarettes, five tobacco and shisha flavors, and a 900mAh battery with 30-minute fast charging. The company positions the device as distinct from HNB and traditional flavored e-cigarettes.
Nov.27 by 2FIRSTS.ai
Thai Police Seize 48,000 Illegal E-Cigarettes Worth About $630,000
Thai Police Seize 48,000 Illegal E-Cigarettes Worth About $630,000
Acting on directives from senior government and police officials, Thai authorities seized 48,301 e-cigarettes and related products in central Thailand, valued at about 20 million baht (approximately US$630,000), as part of a crackdown on illegal vaping.
Oct.15 by 2FIRSTS.ai
Scandinavian Tobacco Group Reports Q3 2025 Results and Narrows Full-Year Guidance
Scandinavian Tobacco Group Reports Q3 2025 Results and Narrows Full-Year Guidance
Scandinavian Tobacco Group (STG) reported net sales of DKK 2.4 billion for Q3 2025, in line with last year. EBITDA before special items reached DKK 519 million with a 22.0% margin. Handmade Cigars and Next Generation Products saw organic growth, while Machine-Rolled Cigars and Smoking Tobacco declined. The company narrowed its full-year guidance.
Nov.12 by 2FIRSTS.ai
Heno Biotech Invited to Speak at PouchEX 2025 in Stockholm, Introduces Supply Chain Competency Model for the Nicotine Pouch Industry
Heno Biotech Invited to Speak at PouchEX 2025 in Stockholm, Introduces Supply Chain Competency Model for the Nicotine Pouch Industry
Heno Biotech was invited to deliver a keynote address at PouchEX Stockholm 2025, presenting a new supply chain competency model for the nicotine pouch sector. The company showcased its end-to-end capabilities—from scientific research and advanced manufacturing to global regulatory compliance—underscoring the critical role of supply chain upgrading in driving sustainable industry growth.
Nov.24